EAU 2020: Perioperative Therapy for Urothelial Cancer: PD-1/PD-L1 Inhibitors are Replacing Perioperative Chemotherapy

(UroToday.com) At the European Association of Urology (EAU) Virtual 2020 meeting’s Immunotherapy and Beyond Thematic session, Dr. Joost Boormans discussed PD-1/PD-L1 inhibitors replacing perioperative chemotherapy for urothelial cancer.